key: cord-0790044-vijs3yq8
authors: Ouyang, J.; Shan, X.; Wang, X.; Zhang, X.; Chen, Y.; Qi, M.; Xia, C.; Gu, D.; Zhang, B.
title: Clinical characteristics of COVID-19 and the model for predicting the occurrence of critically ill patients: a retrospective cohort study.
date: 2020-08-14
journal: nan
DOI: 10.1101/2020.08.13.20173799
sha: 33fdbc1b4cc6cc13345ff7ca588b705faaffa39d
doc_id: 790044
cord_uid: vijs3yq8

Background: The present study aim to comprehensively report the epidemiological and clinical characteristics of the COVID-19 patients and to develop a multi-feature fusion model for predicting the critical ill probability. Methods: It was a retrospective cohort study that incorporating the laboratory-confirmed COVID-19 patients in the Chongqing Public Health Medical Center. The prediction model was constructed with least absolute shrinkage and selection operator (LASSO) logistic regression method and the model was further tested in the validation cohort. The performance was evaluated by the receiver operating curve (ROC), calibration curve and decision curve analysis (DCA). Results: A total of 217 patients were included in the study. During the treatment, 34 patients were admitted to intensive care unit (ICU) and no developed death. A model incorporating the demographic and clinical characteristics, imaging features and laboratory findings were constructed to predict the critical ill probability and it was proved to have good calibration, discrimination ability and clinic use. Conclusions: The prevalence of critical ill was relatively high and the model may help the clinicians to identify the patients with high risk for developing the critical ill, thus to conduct timely and targeted treatment to reduce the mortality rate.

Background: The present study aim to comprehensively report the epidemiological 24 and clinical characteristics of the COVID-19 patients and to develop a 25 multi-feature fusion model for predicting the critical ill probability. 26 Methods: It was a retrospective cohort study that incorporating the laboratory- [1] . The novel coronavirus, named severe acute respiratory 48 syndrome 2 (SARS-CoV-2) was quickly isolated and the virus-infected pneumonia 49 was later designated as coronavirus disease 2019 (COVID-19) by The World Health 50 Organization (WHO) [2] . Since then, the number of patients has increased rapidly, 51 with confirmed cases successively appearing in many Chinese provinces 52 (municipalities, autonomous regions and special administrative regions) and other 147 53 countries, areas or territories [3, 4] . As of August 1st, 2020, the globally reported 54 laboratory-confirmed cases were nearly 1,900 thousands and WHO has declared 55 COVID-19 as an international pandemic public health emergency [3, 5] . 56 Up to now, a series of studies try to explain the clinical characteristics of 57 COVID-19 and the clinical spectrum was reported to range from asymptomatic 58 infection to severe pneumonia that should be admitted to the intensive care unit (ICU) 59 and even death [6] [7] [8] [9] . With the emergence of the second or third-generation infection 60 of COVID-19, more clinical characteristics in other areas besides Wuhan need to be 61 reported. Chongqing has 40 districts under its jurisdiction, being the largest 62 municipality in China that adjacent to Wuhan. Until now, a total of 583 patients were 63 diagnosed in Chongqing, but the clinical spectrums were not reported before [4] . 64 Most of the COVID-19 patients were reported to have mild symptoms and a 65 relatively better prognosis, while the critical ill patients hold poor prognosis and pose 66 high risk for death [9, 10] . There is no specialized medicine to cure COVID-19 and 67 the supportive care became the mainstay treatment regimen [11] . Therefore, to early 68 identify the patients with high risk for developing critical ill and provide targeted care 69 and treatment may prevent the patients from progression and reduce mortality risk, 70 however, the valid tools are lacking. 71 Thus, in the present study, we aim to describe the epidemiological and clinical 156 A total of 34 critical ill patients (15.7%) were admitted to ICU. The prevalence 157 of critical ill was significantly increased with age and peaked at 61-70 years (33.3%; 158 95%CI: 19.5%-50.8%) then decreased. ( Figure 2D ) The prevalence in male and 159 females presented different trends with age, however no difference was found in the 160 total critical ill prevalence between them (18.8% for male, 12.9% for female, ꭓ 

Chongqing 

A Novel Coronavirus from Patients with 289

World Health Organization. WHO Director-General's remarks at the media briefing 292 on 2019-nCoV on 11

World Health Organization. WHO. Novel coronavirus (COVID-19) Situation

Center for Systems Science and Engineering. COVID-19 Dashboard by the CCSE

Clinical Characteristics of 138 Hospitalized Patients 305 With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Epidemiological and clinical characteristics of 99 308 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical Characteristics of Coronavirus Disease 2019 311 in China

Clinical features of patients infected with 2019 novel 314 coronavirus in Wuhan

Clinical course and risk factors for mortality of adult 317 inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical course and outcomes of critically ill patients 320 with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, 321 observational study

Clinical management of severe acute respiratory 324 infection when novel coronavirus (nCoV) infection is suspected

Kidney disease: improving global outcomes (KDIGO) acute kidney injury work 327 group. KDIGO clinical practice guideline for acute kidney injury

Sepsis-3)

Regression shrinkage and selection via the lasso: a retrospective

Comparing the Areas under Two 336 or More Correlated Receiver Operating Characteristic Curves: A Nonparametric 337 Approach

Decision curve analysis: a discussion

Making

A Familial Cluster of Pneumonia Associated 341 With the 2019 Novel Coronavirus Indicating Person-To-Person Transmission: A 342 Study of a Family Cluster

Early Transmission Dynamics in Wuhan, China, of 345 Novel Coronavirus-Infected Pneumonia